Critical Care Medicine
Response to recombinant factor VIIa predicted patients with severe hemorrhage
Published in Blood Weekly, November 16th, 2006
"Despite increasing use of rFVIIa in non-haemophiliac patients, it is unclear when rFVIIa might be effective. A single centre review of consecutive non-haemophiliac patients receiving rFVIIa for the management of severe haemorrhage," wrote K.M. Bowles and colleagues, Addenbrookes Hospital.
"Treatments with rFVIIa were at a dose of 90 mcg kg-1 repeated at three hourly intervals at the clinicians' discretion. Eighteen patients received rFVIIa. Six patients survived to discharge and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-11-16)
More Articles from Blood Weekly
- Blood Banking
Platelet preparation methods compared - Blood Transfusion
Safe Blood for Africa conducts west/central African donor recruitment workshop - Tissue Engineering
Culture with human serum facilitates tissue engineering of nasal septal cartilage - Tissue Engineering
Real-time system monitors cell aggregation and trajectories in rotating wall vessel bioreactors - Tissue Engineering
Three-dimensional tissue-engineered bone fabricated in a rotating bioreactor - Ebola Fever
Researchers at University of Tokyo, Institute of Medical Science publish new data on ebola fever - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
